PAI Partners Acquires 67% Stake in VAMED's European Rehabilitation Business from Fresenius
May 2, 2024
PAI Partners will acquire a 67% stake in VAMED's pan‑European rehabilitation business from Fresenius, with Fresenius retaining a 33% stake. The carved‑out business operates 67 clinics across multiple European countries, employs around 10,000 staff and will operate as a standalone rehabilitation platform focused on operational excellence and further investment.
- Buyers
- PAI Partners, Fresenius SE & Co. KGaA
- Targets
- VAMED's European rehabilitation business
- Sellers
- Fresenius SE & Co. KGaA
- Industry
- Healthcare Services
- Location
- Vienna, Austria
- Transaction Type
- Divestiture
Explore More
Related Acquisitions
-
Macquarie Infrastructure and Real Assets Acquires Viamed Salud
October 20, 2020
Healthcare Services
Macquarie Infrastructure and Real Assets (via Macquarie European Infrastructure Fund 6) has acquired Spanish private healthcare group Viamed Salud from a consortium of private investors. Viamed Salud operates a network of acute hospitals, convalescence centres and outpatient clinics across multiple Spanish regions; Macquarie said the investment targets long-term growth driven by an ageing population and expansion of private healthcare in Spain.
-
PAI Partners and Ontario Teachers' Acquire Veonet from Nordic Capital
December 3, 2021
Healthcare Services
PAI Partners and the Ontario Teachers' Pension Plan Board have agreed to acquire Veonet, a pan‑European network of ophthalmology clinics, from Nordic Capital. Veonet is headquartered in Munich and operates more than 190 clinics across Germany, the UK, the Netherlands and Switzerland, treating over 1.2 million patients annually; financial terms were not disclosed and the deal is subject to regulatory approvals.
-
PAI Partners Acquires Apleona from EQT for ~€1.6bn
December 6, 2020
Industrial Services
PAI Partners has agreed to acquire Apleona Group GmbH from EQT (EQT VII) for approximately EUR 1.6 billion. Apleona, headquartered in Neu-Isenburg, Germany, is a leading European technical and integrated facility management provider with more than 20,000 employees and a strong position in the DACH region; PAI said it will pursue further consolidation and growth both organically and via M&A.
-
Olympus Partners Acquires PAI Pharma
February 24, 2025
Pharmaceuticals
Olympus Partners has acquired PAI Pharma, a leading U.S. developer, manufacturer and distributor of generic oral liquid medicines. The platform was previously owned by Enhanced Healthcare Partners and Bourne Partners Strategic Capital; terms were not disclosed and Monroe Capital provided senior financing for the deal.
-
PAI Partners Agrees to Acquire Majority Stake in Amplitude Surgical
July 30, 2020
Medical Devices
PAI Partners has entered into exclusive negotiations to acquire a majority stake in Amplitude Surgical from Apax Partners and certain managers via an SPV, at a price of €2.15 per share, with a subsequent mandatory public tender offer planned. The transaction preserves existing management involvement and is intended to support Amplitude Surgical's continued international expansion and product development in lower-limb orthopedics.
-
Fremman Capital Acquires Majority Stake in rehaneo from Gimv
November 20, 2024
Healthcare Services
Fremman Capital has agreed to acquire a majority stake in German outpatient rehabilitation group rehaneo from European investment company Gimv. The founders Bruno Crone and Christoph Dühr remain significant shareholders and will continue to run the business; the deal is subject to German antitrust approval and is expected to close in Q1 2025.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.